Search

Nottingham University in the UK opened a new GBP4.4 million centre for clean chemistry and engineering.

Anti-trust legislation, particularly involving raids at dawn, is no way to improve productivity in the pharmaceutical industry, says Nuala Moran.

Intrapreneur Jean Stéphenne, manager of GSK Biologicals, has transformed the company’s research organisation and revolutionised the global vaccines market.

Ireland’s remarkable ability to attract inward investment has made it the economic role model for aspiring small countries. Now it plans to lure corporate R&D.

The Romanian government is launching a campaign to make science and technology development a key to prosperity and peace in the strife-torn Western Balkans.

By all means focus on funding – but let’s spend more on fundamentally redesigning educational systems: less energy on testing outdated models and more on trying new technologies.

As Framework Programme 7 fires up, Europe’s auditors throw on some cold water. Nuala Moran wonders how we will assess whether it has all been worthwhile.

Croatia and Norway have signed up to the European Patent Convention taking the total number of European Patent Organisation member states to 34.

Research actors within the Western Balkans face a number of challenges in gaining the full benefit of participation in EU research programmes.

If the Western Balkans region is to improve the overall position of its science and technology, what are the obstacles to overcome?

Can investment in science and technology help bring stability and prosperity to one of Europe’s oldest trouble-spots?

The European Commission has selected six areas of pioneering research for its long-awaited lead markets initiative.

Over half of the students entering European universities are women – but the higher one goes in the research hierarchies, the more women seem to disappear.

Using Europe’s €1,700 billion annual public procurement budget to stimulate innovation is an idea whose time is coming – slowly.